Daclatasvir，BMS-790052 CAS NO.1009119-64-5

FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
Min.Order: 100 Gram
Payment Terms: L/C
Available Specifications:
≥98.0%(100-500)Gram1/Gram100USD≥98.0%(1000-5000)Gram1/Gram1000USD

Product Details

Keywords

1009119-64-5
Daclatasvir，BMS-790052
dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;diMethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'

Quick Details

ProName: Daclatasvir，BMS-790052
CasNo: 1009119-64-5
Molecular Formula: C40H50N8O6
Appearance: off white powder
Application: Signal transduction pathway kinase inh...
DeliveryTime: 3 months
PackAge: 100g,500g,1kg,25kg/drum
Port: shang hai
ProductionCapacity: 1000 Gram/Week
Purity: ≥98.0%
Storage: Dry seal
Transportation: shipping
LimitNum: 100 Gram

Superiority

We are specialized in custom synthesis, chemical/pharmaceutical/ pesticides outsourcing and contract research.

We are committed to provide excellence in researching, manufacturing and drug discovery process.

Our research team of scientists consists of western-trained Ph.D.s with experience and capabilities in drug R&D methodologies and medicinal chemistry.

Details

Daclatasvir (BMS-790052; EBP 883) is a first-in-class, highly-selective oral HCV NS5A inhibitor.
IC50 Value: 9-50 pM (EC50)
Target: HCV NS5A
NS5A is an essential component for hepatitis C virus (HCV) replication complex.Daclatasvir (BMS-790052; EBP 883)has broad genotype coverage and exhibits picomolar in vitro potency against genotypes 1a (EC50 50pm) and 1b (EC50 9pm).Daclatasvir (BMS-790052; EBP 883) produces a robust decline in HCV RNA (-3.6 logs after 48 hours from a single 100 mg) dosefollowing a single dose in patients chronically infected with HCV genotype 1.

Daclatasvir，BMS-790052 CAS NO.1009119-64-5

Keywords

Quick Details

Superiority

Details

Other products of this supplier